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 Social competence scale and Behavior problem scale of 1217 years
old
Male
12-17
(N 38)
Mean  SD
Standard of
Male
Mean  SD
Female
12-17
(N 25)
Mean  SD
Standard of
Female
Mean  SD
< Social
competence
>
Socialization 5.63  2.08 5.48  1.39 6.09  1.80 5.55  1.29
Studying
competence 3.60  0.88 3.83  0.77 3.78  0.77 3.84  0.70
Total Social
competence 9.33  2.64 9.31  1.69 10.13  2.05 9.39  1.58
< Behavior
problems >
Withdrawan 2.92  2.47 2.51  2.60 3.48  3.15 2.81  2.86
Somatic
Complaints 3.42  3.46 2.11  2.35 2.56  2.70 2.64  2.73
Anxious /
Depressed 4.13  3.36 3.31  3.47 5.84  4.65 4.18  4.08
Social Problems 3.47  2.79 1.93  2.19 3.00  2.19 1.90  2.09
Thought
Problems 1.07  1.34 0.83  1.31 1.52  1.32 0.80  1.41
Attention
Problems 4.13  2.80 4.25  3.43 4.76  3.21 3.97  3.30
Delinquent
Behavior 0.97  1.07 1.64  2.10 1.36  1.43 1.20  1.94
Aggressive
Behavior 5.21  3.89 5.36  5.30 6.92  3.49 5.90  5.07
Internalizing
Problems 10.23  6.90 7.80  6.98 11.48  8.38 9.37  8.11
Externalizing
Problems 6.18  4.35 7.00  6.63 8.28  4.55 7.10  6.47
Total Behavior
Promblems 28.97  16.50 25.73  20.63 32.64  16.73 26.83  21.72
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FUNDAMENTAL NURSING RESPONSIBILITIES IN MESENCHYMAL STEM
CELL INFUSION
Maldonado, M.1, Kebriaei, P.1, Granada, M.L.A.1, Szewczyk, N.1
1MD Anderson Cancer Center, Houston, TX.
Prevention and treatment of graft versus host disease (GVHD)
continues to be a challenge in the ﬁeld of Stem Cell Transplanta-
tion and Cellular Therapy (SCTCT). It may take multidrug ther-
apy with different mechanisms to control GVHD. Mesenchymal
Stem Cell (MSC) infusion is a new form of cellular therapy, which
may be potentially efﬁcacious in the treatment of GVHD. MSC
have the unique capability of differentiating into various tissues,
and can help in the repair process necessary in GVHD. These are
cells obtained in the adult bone marrow that may assist to control
how the immune system responds to foreign substances and nur-
ture the growth of new blood cells in the bone marrow. Finally, it
has immunomodulatory effects that are essential in treating
GVHD.
SCTCT nurses play a vital role in managing the care of patients
with GVHD. It is imperative that they have a strong knowledge
base of the accountabilities that surround them when involved in
the care of a patient receiving MSC. Close monitoring for possible
toxicities and serious adverse effects pre-, during and post infu-
sions, and proper documentation of assessments and ﬁndings, are
important as well. Upon understanding such, this will aid them to
immediately identify complications and relay accurate ﬁndings to
the physicians. Patient teaching plays an enormous role in the
administration of MSC because a well- informed patient is able to
comprehend their treatment, therefore, being proactive with their
care.
The tool developed to assist SCTCT nurses to identify the
standard procedures, such as pre-printed orders, the nursing re-
sponsibilities pre, during and post transfusion of MSC and a case
study will be presented. Consideration to incorporate this infor-
mation into annual competency check is being discussed.
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THE ROLE OF IMMUNOGLOBULIN IN HEMATOPOIETIC STEM CELL
TRANSPLANTATION
Martin, A.1, Neumann, J.1 1The University of Texas M.D. Anderson
Cancer Center, Houston, TX.
Topic/Purpose:
It is critical to be knowledgeable about the indications, mecha-
nisms of action (MOA), and administration of medications and
treatments delivered in order to educate patients, eliminate med-
ication errors, and watch for harmful side effects. Intravenous
Immunoglobulin (IVIg) is a complex drug administered frequently
by nurses to certain patients receiving a hematopoietic stem cell
transplant (HSCT) as a standard of care for infection prevention,
and for other, lesser-known uses. In conversations with staff nurses
and new graduate nurses, a serious need has been identiﬁed to
educate nurses about the indications, MOA, and administration of
IVIg to ensure patient safety and improve nursing knowledge.
Intervention:
A presentation will be offered to nurses working with HSCT
patients exploring the current uses and indications of IVIG, how it
works, precautions for administration, and investigational uses.
Discussion:
Infection is the number one complication in patients receiving a
HSCT. Approximately half of all the patients receiving unrelated
donor stem cells develop at least one major, life-threatening infec-
tion post-transplant. IVIg is an infusion frequently used in patients
to help prevent or reduce the occurrence of these infections.
Immunoglobulins are antibodies found in the blood serum that
play a key role in identifying and destroying harmful foreign bodies
or antigens. These antibodies are subject to myelosuppressive
agents such as high-dose chemotherapy or immunosuppressants
after transplantation. IVIg is given to these patients to replace and
supplement the immunoglobulin deﬁciency. Although there is
some controversy surrounding its use, studies have suggested that
regular supplementation in these patients help prevent major in-
fections.
There are multiple issues related to the administration of IVIg. It
is derived from human blood products, therefore patients are at
risk for reactions during infusion. Nurses must be aware of all
possible reactions and monitor the patients during administration.
Evaluation:
Intravenous Immunoglobulin competency for nursing staff and
post testing for effectiveness is being developed.
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MORE THAN MY MARROW: DEVELOPMENT AND IMPLEMENTATION OF
A HEMATOPOIETIC STEM CELL DONOR RECOGNITION PROGRAM
McMullin, B.1, Sorensen, S.1, Choroszy, M.1, Carstens, K.1 1M.D.An-
derson Cancer Center and Children’s Cancer Hospital, Houston, TX.
Although alternative stem cell sources have expanded the hema-
topoietic stem cell transplant (HSCT) repertoire, a signiﬁcant
number of HSCT recipients still receive stem cells from related
donors. Related donors are frequently minor or adult-aged sib-
lings, but parents, children and other relatives of recipients may be
called upon to donate. Most donors are altruistic, but nonetheless
feel tremendous pressure to donate and can experience distress. Up
to half of the donors may face difﬁculties, which include sleep
disturbances, behavior problems, and poor academic achievement.
Feelings of resentment and guilt are commonly expressed. Pre-
donation ambivalence, donor’s perception of the adequacy of in-
formation provided, donor’s participation in the decision to do-
nate, and the quality of donor-recipient relationship are four
variables that have been associated with donor distress. Services
provided to donors are variable and often only related to immedi-
ate procedural concerns with little post-donation follow-up. Given
the frequent and signiﬁcant related donor and potential donor
distress, prophylactic services should be implemented to assist
donors with not only the procedural and physical issues but also the
psychosocial issues. Approximately 300 related HSCT donors are
chosen annually at our institution. Such prophylactic service pro-
vision is currently absent for the adult-aged related donors, and is
limited for minor-aged related donors to the obtaining of assent
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